Motiron (Methylphenidate Hydrochloride)

Methylphenidate Hydrochloride, the active ingredient in Motiron, is a central nervous system stimulant presented as an oral tablet for oral use. It is indicated for the treatment of attention deficit hyperactivity disorder and narcolepsy in children, adolescents, and adults.

GNH USA supplies Motiron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Motiron is a central nervous system stimulant indicated for the following conditions:

- Attention Deficit Hyperactivity Disorder (ADHD): Improves attention, reduces hyperactivity and impulsivity in children and adolescents. - Attention Deficit Hyperactivity Disorder (ADHD) in adults: Enhances focus and occupational functioning. - Narcolepsy: Decreases excessive daytime sleepiness and promotes sustained wakefulness.

Common Side Effects: - Insomnia: Difficulty falling or staying asleep. - Decreased appetite: Reduced hunger leading to weight loss. - Headache: Mild to moderate cranial pain. - Stomach pain: Gastrointestinal discomfort. - Irritability: Mood changes and increased agitation. - Weight loss: Unintended reduction in body weight.

Serious or Rare Side Effects: - Cardiovascular events: Hypertension, tachycardia, or arrhythmias. - Psychosis: Hallucinations or delusional thinking. - Severe allergic reaction: Rash, swelling, or anaphylaxis. - Priapism: Persistent, painful erection. - Tics or worsening of existing tics. - Mania or bipolar exacerbation.

Before initiating Motiron, clinicians should consider the following precautions: - Assess cardiovascular status: Evaluate blood pressure and heart rate prior to therapy. - Monitor growth in children: Track height and weight regularly during treatment. - Avoid use in patients with known hypersensitivity: Discontinue if allergic reactions occur. - Use caution with concomitant MAO inhibitors: Ensure an appropriate wash‑out period. - Avoid abrupt discontinuation: Taper the dose under medical supervision. - Store at ambient temperature: Keep in the original container, protect from moisture and heat.

Motiron may interact with several drug classes. Review the following:

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): Risk of hypertensive crisis; concurrent use is contraindicated. - Tricyclic antidepressants: May increase cardiovascular side effects. - Antipsychotics: Can reduce stimulant efficacy. - Sympathomimetic agents: Additive stimulant effects may cause severe hypertension. - Certain antihypertensive agents: May diminish blood‑pressure‑lowering effect.

Moderate Interactions (Monitor Closely):\n- CYP2D6 inhibitors (e.g., fluoxetine): May raise methylphenidate plasma levels; monitor for toxicity. - Antihypertensives: Potential attenuation of blood‑pressure control; observe blood pressure regularly.